Andersen-Tawil syndrome tertiary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Andersen-Tawil syndrome}} {{CMG}} ==Tertiary Prevention== The following precautions should be taken to prevent complications in a patient with Andersen-Tawil synd..." |
No edit summary |
||
| Line 6: | Line 6: | ||
The following precautions should be taken to prevent complications in a patient with Andersen-Tawil syndrome: | The following precautions should be taken to prevent complications in a patient with Andersen-Tawil syndrome: | ||
* Caution while prescribing certain antiarrhythmics such as those belonging to class I as they may paradoxically exacerbate the neuromuscular symptoms. | * Caution while prescribing certain antiarrhythmics such as those belonging to class I as they may paradoxically exacerbate the neuromuscular symptoms. | ||
* Caution should be maintained while administering anesthesia to these patients to prevent malignant hyperthermia. | * Caution should be maintained while administering anesthesia to these patients to prevent malignant hyperthermia. | ||
Revision as of 21:37, 24 February 2013
|
Andersen-Tawil syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Andersen-Tawil syndrome tertiary prevention On the Web |
|
American Roentgen Ray Society Images of Andersen-Tawil syndrome tertiary prevention |
|
Risk calculators and risk factors for Andersen-Tawil syndrome tertiary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Tertiary Prevention
The following precautions should be taken to prevent complications in a patient with Andersen-Tawil syndrome:
- Caution while prescribing certain antiarrhythmics such as those belonging to class I as they may paradoxically exacerbate the neuromuscular symptoms.
- Caution should be maintained while administering anesthesia to these patients to prevent malignant hyperthermia.